2021
DOI: 10.1016/j.spinee.2020.10.012
|View full text |Cite
|
Sign up to set email alerts
|

A cost benefit analysis of increasing surgical technology in lumbar spine fusion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
46
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 36 publications
(46 citation statements)
references
References 30 publications
0
46
0
Order By: Relevance
“…Most studies were then excluded because they did not meet the “cost‐utility analyses” criterion, or because they were not primary studies reporting results of an economic evaluation (e.g., reviews), or because they were duplicates. After the full‐text screening, 31 studies 31–61 were included for data extraction and quality assessment. Further details are presented in the PRISMA flow diagram (Figure 1).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…Most studies were then excluded because they did not meet the “cost‐utility analyses” criterion, or because they were not primary studies reporting results of an economic evaluation (e.g., reviews), or because they were duplicates. After the full‐text screening, 31 studies 31–61 were included for data extraction and quality assessment. Further details are presented in the PRISMA flow diagram (Figure 1).…”
Section: Resultsmentioning
confidence: 99%
“…Table 1 lists the characteristics and main findings of the included studies. Thirty‐one 31–61 eligible studies evaluated CUAs of robotic surgery compared with that of laparoscopic surgery, open surgery, and (chemo) radiotherapy, and they were published between 2011 and 2020. Studies were conducted in the following countries: USA ( n = 8 31,33,36,42,49,58,60,61 ), Spain ( n = 8 43,45,47,48,50,51,54,59 ), Canada ( n = 5 35,37,39,41,57 ), UK ( n = 2 32,44 ), Thailand ( n = 2 34,40 ), Finland ( n = 1 46 ), Italy ( n = 1 53 ), Japan ( n = 1 55 ), Lebanon ( n = 1 38 ), Sweden ( n = 1 56 ), and China ( n = 1 52 ).…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Recent technologies often need expensive support to develop, and after verifying the efficacy of surgery, they will be further promoted and developed to reduce the cost of surgery and bring well-being to critically ill patients. 56 , 57 Comparative studies on the fusion rates of MI-TLIF and O-TLIF in patients with obesity are required to further evaluate their efficacy.…”
Section: Discussionmentioning
confidence: 99%